Suchergebnisse - "Morrison, Kirsty"

PubPharm (15)

1

Incidence, management and prognosis of new-onset sarcoidosis post COVID-19 infection

enthalten in: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG | 2024

von Vij, O. | Dey, M. | Morrison, K. | +1

2

Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer : Primary Outcomes of the SPARC Phase 2 Trial

enthalten in: International journal of radiation oncology, biology, physics | 2024

von Yasar, B. | Suh, Y. | Chapman, E. | +11

3

Undervaccination and severe COVID-19 outcomes : meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales

enthalten in: Lancet (London, England) | 2024

von HDR UK COALESCE Consortium | Kerr, S. | Bedston, S. | +25

4

Caveats in reporting of national vaccine uptake

enthalten in: Journal of global health | 2024

von Millington, T. | Morrison, K. | Jeffrey, K. | +12

5

Estimated number of lives directly saved by COVID-19 vaccination programs in the WHO European Region, December 2020 to March 2023

enthalten in: bioRxiv.org | 2024

von Mesle, M. | Brown, J. | Mook, P. | +63

6

Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland : Two retrospective cohort analyses of the primary schedule and third dose

enthalten in: Vaccine | 2023

von Morrison, K. | Cullen, L. | James, A. | +15

7

The dermatologist identity crisis : a phenomenological analysis of dermatology trainee professional identity during generalist redeployment

enthalten in: Clinical and experimental dermatology | 2023

von Guckian, J. | Lee, N. | Sutton, J. | +4

8

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B) : 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

enthalten in: The Lancet. Oncology | 2022

von Tree, A. | Ostler, P. | van der Voet, H. | +50

CommentIn: Lancet Oncol. 2022 Dec;23(12):e530. - PMID 36455579

9

Artificial intelligence and the NHS : a qualitative exploration of the factors influencing adoption

enthalten in: Future healthcare journal | 2021

von Morrison, K.

10

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer : Initial results of the SPARC trial

enthalten in: Clinical and translational radiation oncology | 2020

von Nicholls, L. | Suh, Y. | Chapman, E. | +7